Record last night’s sleep each morning
Record bedtimes, wake times and sleep quality to understand your sleep pattern.
Sleep records guide a personalized sleep schedule and six weeks of cognitive behavioral therapy.
MFDS authorization 23-511 · Used with a prescription


With European CE marking and a clinical study with Charité Berlin, SleepQ® is preparing to enter the German market.
Daily sleep records guide your sleep schedule and treatment program.

Record bedtimes, wake times and sleep quality to understand your sleep pattern.
From week 2, recommended sleep times are guided by your records and updated weekly.
Learn through Sleep Exploration, find answers in Sleep Talk and practice relaxation exercises.
Screens from the user guide; the software may differ by software version.
Complete the initial questionnaire and record your sleep each day.
Your recommended sleep schedule is updated weekly as you follow the treatment program.
Review your outcomes with your clinician using the final questionnaire and sleep records.
Improvement in sleep efficiency from baseline
Sleep efficiency is the proportion of time in bed spent asleep. Bars show adjusted changes from baseline in percentage points (pp).
SleepQ® improved sleep efficiency by 8.28 percentage points more than the sham software control.
A percentage point (pp) is the unit used for the difference between two percentages.
p = 0.0418An RWE analysis of patients prescribed SleepQ® estimated an average 6.59-point reduction in the Insomnia Severity Index (ISI) from before to after treatment.
Participating hospitals
Average ISI change from before treatment
The ISI is a questionnaire that measures insomnia symptom severity. Lower scores indicate less severe symptoms, so a lower average score reflects improvement.
23-511 · Innovative device No. 25
A pathway from authorization to clinical use
TU001 prescribing · TU002 evaluation · TX010 use fee (non-covered)
Full-scale commercial rollout to hospitals
The SleepQ® usage fee is a recognized non-covered item, distinct from National Health Insurance benefit coverage. Confirm charges with the provider and private coverage with your insurer.
HIRA guidance ↗MFDS 23-511, April 2023 · Innovative device No. 25 · CE(MDR), 2025
DrugOS™ · CBT-I